Bowel (colorectal) cancer, Colon cancer, Rectal cancer
Results
Phase 2
This trial looked at cetuximab on its own or with irinotecan for bowel cancer that had spread to another part of the body (advanced bowel cancer).
Recruitment start: 1 November 2012
Recruitment end: 30 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Harpreet Wasan
Australasian GastroIntestinal Trials Group (AGITG)
Experimental Cancer Medicine Centre (ECMC)
Imperial College Healthcare NHS Trust
Merck Serono
NIHR Clinical Research Network: Cancer
Last reviewed: 10 May 2018
CRUK internal database number: 10621